Viking Therapeutics Inc (VKTX · NASDAQ)
VKTX · MARKET VIEW
Market view · as of Aug 24, 2026
Revenue (TTM)
$0
0.0% YoY
EPS (latest q)
$-1.10
vs $-1.21 est · beat
52-wk position
56.7%
-19.6% vs 52w high · -2.6% 1mo
Price (last ~year)
Clinical-stage biopharmaceutical company Viking Therapeutics (VKTX) maintains a $3.95 billion market capitalization while reporting zero revenue and a $132.6 million operating loss for the quarter ended June 30, 2026. The firm holds $125.8 million in cash against $4.1 million in debt, with recent updates confirming that late-stage trials for its obesity drug VK2735 are fully enrolled. Shares currently trade at $33.89, representing a 7.0% increase over the last three months.
Valuation
- Market cap
- $3.95B
- PEG
- -0.03
- P/B
- 9.68
- EV/EBITDA
- -71.64
- Beta
- 0.685
- Analyst target
- $92.39
Quality & returns
- Operating margin
- 0.0%
- Profit margin
- 0.0%
- ROE
- -88.8%
- ROA
- -51.9%
Price movement
- Last
- $33.89
- 1-month
- -2.6%
- 3-month
- +7.0%
- RSI (14)
- 57
- vs SMA200
- +0.5%
- 52-wk position
- 56.7% -19.6% vs high
Quarterly trajectory
Revenue by quarter (oldest → newest)
| Quarter | Revenue | Op income | Net income | EBITDA |
|---|---|---|---|---|
| 2026-06-30 | $0 | $-132.6M | $-128.0M | $-127.9M |
| 2026-03-31 | $0 | $-164.1M | $-158.3M | $-158.3M |
| 2025-12-31 | $0 | $-164.7M | $-157.7M | $-157.6M |
| 2025-09-30 | $0 | $-98.6M | $-90.8M | $-90.7M |
Recent news
- Neutral VKTX Stock Steady After-Hours On Positive Obesity Drug Pipeline Progress · 2026-08-21
- Neutral Viking Therapeutics (NASDAQ:VKTX) Upgraded to Hold at Zacks Research · 2026-08-20
- Neutral Viking Therapeutics (VKTX) Stock Still Looks Pricey With Pipeline Hopes Priced In · 2026-08-19
- Neutral Timothy G. Youngquist 2020 Irrevocable Trust Has $10.61 Million Position in Viking Therapeutics, Inc. $VKTX · 2026-08-19
- Bullish LLY, NVO Stocks Led May’s GLP-1 Rally — But This Smaller ‘Differentiated Player’ Got A Bold 160% Upside Call · 2026-08-19
- Neutral Viking Therapeutics, Inc. Revenue Breakdown – NASDAQ:VKTX · 2026-08-18
Sources this view read
- fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
- filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
- earnings Reported earnings history (Alpha Vantage EARNINGS)
- prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)